Cardiovascular disease-risk factors in middle-aged osteopaenic women treated with calcium alone or combined to three nutrients essential to artery and bone collagen

Journal of Human Nutrition and Dietetics

Volumn 21, Issue 2, 2008, Pages 117-128

  Massé, Priscille G ^a   Tranchant, C C ^a   Jougleux, J L ^a   Coburn, S P ^b   Cole, D E ^c  

^a UNIVERSITÉ DE MONCTON   (Canada)

^b PURDUE UNIVERSITY FORT WAYNE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Calcium; Cardiovascular disease risk factors; Collagen; Homocysteine; Osteoporosis; Proline; Pyridoxal'5 phosphate; Vitamins C and B6

Indexed keywords

ASCORBIC ACID; CALCIUM CARBONATE; CHOLESTEROL; COLLAGEN; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLACEBO; PROLINE; PYRIDOXIC ACID; PYRIDOXINE; TRIACYLGLYCEROL;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BONE DENSITY; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEART PROTECTION; HUMAN; INTERVENTION STUDY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MIDDLE AGED; MONOTHERAPY; NUTRIENT SUPPLY; OSTEOPENIA; PATIENT COMPLIANCE; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RISK FACTOR; RISK REDUCTION; TREND STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ASCORBIC ACID; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CALCIUM CARBONATE; CALCIUM, DIETARY; CARDIOVASCULAR DISEASES; CHOLESTEROL; DRUG THERAPY, COMBINATION; FEMALE; HOMOCYSTEINE; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; POSTMENOPAUSE; PROLINE; PYRIDOXIC ACID; RISK FACTORS; VITAMIN B 6;

EID: 40949120928     PISSN: 09523871     EISSN: 1365277X     Source Type: Journal    
DOI: 10.1111/j.1365-277X.2008.00852.x     Document Type: Article

References (51)

1. Adami, S., Braga, V., Guidi, G., Gatti, D., Gerardi, D.A. & Fracassi, E. (2000) Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol. J. Bone Min. Res. 15, 599-604.
2. Anabtharamaiah, G.M., Hughes, T.A., Iqbal, M., Gawish, A., Neame, P.J., Medley, M.F. & Segrest, J.P. (1988) Effect of oxidation on the properties of apolipoproteins A-I and A-II. J. Lipid Res. 29, 309-318.
3. Barengolts, E.I., Berman, M., Kukreja, S.C., Kouznetsova, T., Lin, C. & Chomka, E.V. (1998) Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif. Tissue Int. 62, 209-213.
4. Bostick, R.M., Fosdick, L., Grandits, G.A., Grambsch, P., Gross, M. & Louis, T.A. (2000) Effect of calcium supplementation on serum cholesterol and blood pressure. A randomized, double-blind, placebo-controlled, clinical trial. Arch. Fam. Med. 9, 31-38.
5. Brattstrom, L., Stavenow, L., Galvard, H., Nilsson-Ehle, P., Berntorp, E., Jerntorp, P., Elmstahl, S. & Pessah-Rasmussen, H. (1990) Pyridoxine reduces cholesterol and low-density lipoprotein and increases antithrombin III activity in 80-year-old men with low plasma pyridoxal 5-phosphate. Scand. J. Clin. Lab. Invest. 50, 873-877.
6. Browner, W.S., Seeley, D.F., Vogt, T.M. & Cummings, S.R. (1991) Non-trauma mortality in elderly women with low bone mineral density. Lancet 338, 355-358.
7. Callaway, C.W., Chumlea, W.C., Bouchard, C., Himes, J.H., Loham, T.G., Martin, A.D., Mitchell, C.D., Mueller, W.H., Roche, A.F. & Seefeldt, V.D. (1988) Circumferences. in: Anthropometric Standardization Reference Manual. eds T.G. Lohman, A.F. Roche & R. Martorell, pp. 39-54. Champaign, IL: Human Kinetics.
8. 6 in cholesterol metabolism. Nutr. Res. 4, 359-362.
9. Denke, M.A., Fox, M.M. & Schulte, M.C. (1993) Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J. Nutr. 123, 1047-1053.
10. Evrovski, J., Callaghan, M. & Cole, D.E. (1995) Determination of homocysteine by HPLC with pulsed integrated amperometry. Clin. Chem. 41, 757-758.
11. Fairfield, K.M. & Fletcher, R.H. (2002) Vitamins for chronic disease prevention in adults: Scientific review. JAMA 287, 3116-3126.
12. Food Nutrition Board Institute of Medicine (2006) Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. Washington, DC: National Academy Press.
13. 6 concentrations and modulation of coronary artery disease risk. Am. J. Clin. Nutr. 79, 992-998.
14. Gannage-Yared, M.H., Azoury, M., Mansour, I., Baddoura, R., Halaby, G. & Naaman, R. (2003) Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J. Endocrinol. Invest. 26, 748-753.
15. de Gomez Dumm, N.T., Giammona, A.M. & Touceda, L.A. (2003) Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine. Lipids Health Dis. 2, 1-7.
16. Govers, M.J. & Van der Meet, R. (1993) Effect of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut 34, 365-370.
17. Jacqmain, M., Doucet, E., Despres, J.P., Bouchard, C. & Tremblay, A. (2003) Calcium intake, body composition and lipoprotein-lipid concentrations in adults. Am. J. Clin. Nutr. 77, 1448-1452.
18. Jacques, P.F., Sulsky, S.I., Perrone, G.A. & Schaefer, E.J. (1994) Ascorbic acid and plasma lipids. Epidemiology 5, 19-26.
19. Jaime, P.C., Oliveira Latorre, M.R., Florindo, A.A., Tanaka, T. & Freitas Zerbini, C.A. (2006) Dietary intake of Brazilian black and white men and its relationship to the bone density of the femoral neck. Sao Paulo Med. J. 124, 267-270.
20. Laroche, M., Pouilles, J.M., Ribot, C., Bendayan, P., Bernard, J., Boccalon, H. & Mazieres, B. (1994) Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin. Rheumatol. 13, 611-614.
21. 6 deficiency in the development of atherosclerosis. Lancet 1, 628-630.
22. de Lorgeril, M., Salen, P., Martin, J.L., Monjaud, I., Delaye, J. & Mamelle, N. (1999) Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study. Circulation 99, 779-785.
23. 6 supplementation prevent the oxidative stress and decrease of prostacyclin generation in homocysteinemic rats. Int. J. Biochem. Cell Biol. 36, 1919-1932.
24. 6 vitamers: Cation exchange HPLC. J. Nutr. Biochem. 1, 659-663.
25. 6 -deficient tarsometatarsal chick cartilage. Scanning Microsc. 4, 667-674.
26. 6 -deficient chicks. J. Nutr. 125, 26-34.
27. Massé, P.G., Rimnac, C.M., Yamauchi, M., Coburn, S.P., Rucker, R.B., Howell, D.S. & Boskey, A.L. (1996) Pyridoxine deficiency affects biomechanical properties of chick tibial bone. Bone 18, 567-574.
28. 6 deficiency. Proc. Soc. Exp. Biol. Med. 217, 97-103.
29. Massé, P.G., Dosy, J., Tranchant, C.C. & Dallaire, R. (2004) Dietary macro- and micronutrient intakes of nonsupplemented pre- and postmenopausal women with a perspective on menopause associated diseases. J. Hum. Nutr. Dietet. 17, 121-132.
30. 6 Pro) on bone density, turnover and metabolism in middle-aged osteopenic women. FASEB J. 19, A56.
31. Meier, C.R., Schlienger, R.G., Kraenzlin, M.E., Schlegel, B. & Jick, H. (2000) HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283, 3205-3210.
32. 6 and folic acid on homocysteine and plasmatic lipids in patients with hyperlipoproteinemic secondary type IV. Arch. Latinoam. Nutr. 55, 28-33.
33. Nagano, Y., Arai, H. & Kita, T. (1991) High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc. Natl. Acad. Sci. USA 88, 6457-6461.
34. Nelson, M., Margetts, B.M. & Black, A.E. (1993) Letter to the Editor. J. Hum. Nutr. Dietet. 6, 79-83.
35. Okamoto, K. (2002) Vitamin C intake and apolipoproteins in a healthy elderly Japanese population. Prev. Med. 34, 364-369.
36. Parhami, F., Morrow, A.D., Balucan, J., Leitinger, N., Watson, A.D., Tintut, Y., Berliner, J.A. & Demer, L.L. (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol. 17, 680-687.
37. Rath, M. (1992) Reducing the risk for cardiovascular disease with nutritional supplements. J. Orthomol. Med. 7, 153-162.
38. Reid, I.R., Mason, B., Horne, A., Ames, R., Clearwater, J., Bava, U., Orr-Walker, B., Wu, F., Evans, M.C. & Gamble, G.D. (2002) Effects of calcium supplementation on serum lipid concentrations in normal older women: A randomized controlled trial. Am. J. Med. 112, 343-347.
39. Rifici, V.A. & Khachadurian, A.K. (1993) Dietary supplementation with vitamins C and E inhibits in vitro oxidation of lipoproteins. J. Am. Coll. Nutr. 12, 631-637.
40. 6 concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 97, 437-443.
41. Ross, P.D., Davis, J.W., Epstein, R.S. & Wasnich, R.D. (1991) Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann. Intern. Med. 114, 919-923.
42. Selhub, J., Jacques, P.F., Bostom, A.G., d'Agostino, R.B., Wilson, P.W., Belanger, A.J., O'Leary, D.H., Wolf, P.A., Schaefer, E.J. & Rosenberg, I.H. (1995) Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N. Engl. J. Med. 332, 286-291.
43. Snedecor, G.W. & Cochran, W.G. (1989) Statistical Methods. Ames, IA: The Iowa State University Press.
44. Tietz, N.W., Ed. (1990) Clinical Guide to Laboratory Tests, 2nd edn, pp. 209-212. Philadelphia, PA: WB Saunders Company.
45. Tinker, D. & Rucker, R.B. (1985) Role of selected nutrients in synthesis, accumulation and chemical modification of connective tissue proteins. Physiol. Rev. 65, 607-657.
46. Ueland, P.M., Refsum, H., Stabler, S.P., Malinow, M.R., Andersson, A. & Allen, R.H. (1993) Total homocysteine in plasma or serum: Methods and clinical applications. Clin. Chem. 39, 1764-1779.
47. Uyama, O., Yoshimoto, Y., Yamamoto, Y. & Kawai, A. (1997) Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 28, 1730-1732.
48. Vandeberg, P.J. & Johnson, D.C. (1993) Pulsed electrochemical detection of cysteine, cystine, methionine, and glutathione at gold electrodes following their separation by liquid chromatography. Anal. Chem. 65, 2713-2718.
49. Wilcken, D.E. & Wilcken, B. (1997) The natural history of vascular disease in homocystinuria and the effects of treatment. J. Inherit. Metab. Dis. 20, 295-300.
50. Witzhum, J.L. (1994) The oxidation hypothesis of atherosclerosis. Lancet 344, 793-795.
51. WHO (World Health Organisation) (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO study group on osteoporosis. Geneva: WHO.